Skip to main content

Table 5 The results of stratified meta-analysis

From: Impact of 2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-D-glucoside on cognitive deficits in animal models of Alzheimer’s disease: a systematic review

Subgroups

Acquisition memory

Retention memory

Studies

Participants

Effect size [95 % CI]

Subgroup differences

Dtudies

Participants

Effect size [95 % CI]

Subgroup differences

Animal species

 APP mice

11

349

−1.84 [−2.62, −1.05]

P = 0.0002

4

144

2.84 [1.35, 4.32]

P < 0.00001

 Balb/c mice

5

124

−0.45 [−0.80, −0.09]

   

 Kunming mice

5

98

−0.84 [−1.27, −0.42]

3

60

1.12 [0.56, 1.67]

 SMP8 mice

6

120

−0.79 [−1.17, −0.41]

6

120

1.36 [0.95, 1.77]

 SD rats

9

208

−2.78 [−4.06, −1.51]

2

48

3.60 [2.63, 4.57]

 Wistar rats

3

105

−1.35 [−1.17, −0.41]

   

Sex

 Male

20

471

−1.59 [−2.12, −1.06]

P < 0.00001

8

168

1.61 [1.17, 2.45]

P = 0.65

 Female

5

124

−0.45 [−0.80, −0.09]

   

 Female & Male

14

409

−1.68 [−2.31, −1.05]

7

204

2.06 [1.15, 2.98]

Model

 Untransgenic

22

535

−1.46 [−1.94, −0.98]

P = 0.99

5

108

1.98 [0.88,3.08]

P = 0.93

 Transgenic

17

469

−1.46 [−2.00, −0.91]

10

264

1.92 [1.28, 2.56]

Dose

 Less 100 mg

21

582

−1.92 [−2.52, −1.32]

P = 0.04

8

216

2.23 [1.34, 3.11]

P = 0.15

 100 mg

11

270

−0.91 [−1.37, −0.45]

3

60

1.25 [0.69, 1.82]

 200 mg

2

64

0.92 [−1.46, −0.39]

   

 300 mg

4

88

−1.01 [−1.46, −0.56]

4

96

1.98 [0.92, 3.05]

Quality

 4

2

60

−2.10 [−5.27, −1.08]

P < 0.00001

1

12

3.86 [1.66, 6.05]

P = 0.006

 5

15

361

−1.26 [−1.64, −0.81]

6

120

1.15 [0.76, 1.55]

 6

15

387

−0.63 [−0.83, −0.42]

3

60

1.56 [0.96, 2.16]

 7

7

196

−3.82 [−4.41, −3.23]

5

180

2.97 [1.71, 4.22]